Donald L. Hagan, LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 26 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
Donald L. Hagan, LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$7,000
+40.0%
1,0000.0%0.01%
+50.0%
Q3 2015$5,0001,0000.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 801,242$3,876,0000.50%
ARMISTICE CAPITAL, LLC 624,000$3,039,0000.18%
Rossmore Private Capital 15,061$73,0000.03%
Sterling Investment Advisors, Ltd. 3,150$15,0000.01%
Squarepoint Ops LLC 14,500$71,0000.00%
JFS WEALTH ADVISORS, LLC 500$2,0000.00%
Close Asset Management Ltd 2,000$10,0000.00%
GROUP ONE TRADING, L.P. 16,900$82,0000.00%
SIMPLEX TRADING, LLC 547$2,0000.00%
Tower Research Capital LLC (TRC) 861$4,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders